Get started
Work

Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences

Year: 2025
Type: article
Study design: Case Report
Abstract: ) in the management of macular oedema across diverse retinal conditions, including diabetic macular oedema, central serous chorioretinopathy, branch retinal vein occlusion and Irvine-Gass syndrome. Eight cases reported significant improvements in best-corrected visual acuity and central macular thickness, with complete resolution of oedema in some instances. CHC was well tolerated, with no adverse effects reported. These findings suggest that CHC is a safe and effective adjunct or standalone therapy for chronic or refractory macular oedema, enhancing anatomical and functional outcomes in real-world settings.
DOI: 10.7573/dic.2025-3-3
Authors: Davide Allegrini, Giuseppe Covello, Alessandra Mancini, Antonino Mancini, Maura Mancini, Mary Romano, Aldo Vecchiarelli, Mario R Romano
Institutions: Humanitas Gavazzeni, University of Pisa, Magna Graecia University, University of Messina, Humanitas University, University of Campania "Luigi Vanvitelli", IRCCS Humanitas Research Hospital, Istituto Neurologico Mediterraneo
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,901
OpenAlex ID: W4410518265
FWCI:
Cites:
Cited by:
Related to: 10